Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy

Epilepsy and Behavior

Volumn 14, Issue 2, 2009, Pages 429-431

  Kellinghaus, Christoph ^a   Berning, Sascha ^a   Besselmann, Michael ^a  

^a Andreas Bannowsky Ltd   (Germany)

Author keywords

Anticonvulsant therapy; Lacosamide; Nonconvulsive status epilepticus

Indexed keywords

ACETYLSALICYLIC ACID; DIAZEPAM; DIMETINDENE; DOMPERIDONE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LORAZEPAM;

ADD ON THERAPY; ADULT; APHASIA; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; ERYTHEMA; FEMALE; HEMIPARESIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NAUSEA; NYSTAGMUS; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT TRANSPORT; PRURITUS; PSYCHOSIS; RASH; TREATMENT OUTCOME; VOMITING;

ACETAMIDES; ADULT; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 59749093137     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.12.009     Document Type: Article

References (22)

1. Shorvon S., Baulac M., Cross H., Trinka E., and Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 49 (2008) 1277-1285
2. Aminoff M.J. Do nonconvulsive seizures damage the brain?-No. Arch Neurol 55 (1998) 119-120
3. Shneker B.F., and Fountain N.B. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 61 (2003) 1066-1073
4. Young G.B., and Jordan K.G. Do nonconvulsive seizures damage the brain?-Yes. Arch Neurol 55 (1998) 117-119
5. Doty P., Rudd G.D., Stoehr T., and Thomas D. Lacosamide. Neurotherapeutics 4 (2007) 145-148
6. Biton V., Rosenfeld W.E., Whitesides J., Fountain N.B., Vaiciene N., and Rudd G.D. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49 (2008) 418-424
7. Lowenstein D.H., and Alldredge B.K. Status epilepticus. N Engl J Med 338 (1998) 970-976
8. Garnett W. Lamotrigine: interactions with other drugs. In: Levy R., Mattson R.H., Meldrum B.S., and Perucca E. (Eds). Antiepileptic drugs. 5th Ed. (2002), Lippincott, Williams & Wilkins, Philadelphia 380-388
9. Jordan K.G., and Hirsch L.J. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 47 Suppl. 1 (2006) 41-45
10. Vespa P. Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "to detect and protect". J Clin Neurophysiol 22 (2005) 99-106
11. Vespa P., Prins M., Ronne-Engstrom E., et al. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg 89 (1998) 971-982
12. Waterhouse E.J., Vaughan J.K., Barnes T.Y., et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 29 (1998) 175-183
13. DeLorenzo R.J., Waterhouse E.J., Towne A.R., et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 39 (1998) 833-840
14. Young G.B., Jordan K.G., and Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 47 (1996) 83-89
15. Yaffe K., and Lowenstein D.H. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 43 (1993) 895-900
16. Litt B., Wityk R.J., Hertz S.H., et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 39 (1998) 1194-1202
17. Knake S., Gruener J., Hattemer K., et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 79 (2008) 588-589
18. Peters C.N., and Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus: experience in 102 adult patients. Seizure 14 (2005) 164-169
19. Sachdeo R, Montouris G, Beydoun A, et al. An open-label, maximum tolerated dose trial to evaluate oral SPM 927 as adjunctive therapy in patients with partial seizures. Poster presenation at the annual meeting of the EFNS, Helsinki, 2003.
20. Ben Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., and Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48 (2007) 1308-1317
21. Nagler J., and Miskovitz P. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress. Am J Gastroenterol 76 (1981) 495-499
22. Misra U.K., Kalita J., and Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 67 (2006) 340-342